CoChat

Rating scales for neurologists

Open access
Hobart, J · 2003 · Journal of Neurology, Neurosurgery & Psychiatry
Cited by 63

The DOI matches its Crossref record.

Abstract

A neurologist once told me that he found the subject of rating scales ''exceedingly dull'', while another found the area ''abstruse''.I have therefore attempted to produce an overview that is helpful and conveys some of the basic principals underlying outcomes measurement and rating scales.Clinicians must realise that because this is an alien and somewhat ''dry'' area, they may need to invest some time to appreciate the issues.Instead of discussing specific scales or rating scales for rehabilitation, which will only be relevant to a limited audience, I have chosen to discuss the importance of rating scales and how to achieve high quality measurement.I hope this makes the text more widely applicable to the neurological community.The take home message is simple; neurologists need to take their rating scales very seriously. WHY ARE RATING SCALES IMPORTANT? cRating scales are important because they are a method of measurement.Measurement is important because inferences are based on it.1 For example, in clinical trials we measure variables (for example, disability), perform statistical tests on the numbers generated by scales, and base conclusions on the results.These conclusions influence patient care, prescribing, policy making, and the expenditure of public funds.Thus, the validity of inferences from clinical trials is directly dependent on the quality of the measurement instruments used.Some measurements are clear cut-for example, mortality rates.However, measurement becomes complex for more abstract, ill defined, ''soft'' outcomes such as patient's perspectives of the impact of disease and their quality of life.If we are serious about using these abstract variables to evaluate clinical practice we must be serious about our attempts to measure them as rigorously as possible.Consider clinical trials of interferons and glatiramer acetate in multiple sclerosis (MS).These trials have produced interesting results: an incontrovertible reduction in relapse rate and accumulation of magnetic resonance image (MRI) lesions over time, but a debatable reduction in the progression of physical disability.These findings have prompted major developments including: research to understand the seemingly complex relation between pathology and disability; calls for definitive studies that are free from pharmaceutical conflicts of interest; a controversial review by the National Institute for Clinical Excellence; and the UK risk sharing scheme for prescribing disease modifying therapies.Despite these major developments, few have questioned seriously how the choice of rating scale may have influenced this course of events.This is highly relevant because these major developments in MS are effectively based on the assumption that Kurtzke's expanded disability scale (EDSS), the rating scale used in most MS treatment trials, was considered adequate enough to handle the task of measuring disability and detecting clinically significant change when it occurs.Unfortunately, data concerning the measurement properties of the EDSS do not give us that confidence.First, the EDSS mixes the measurement of different health domains-that is, impairment in the early part of the scale, mobility in the mid range of the scale, and bulbar function in the upper part of the scale.As such, the EDSS is not a pure disability measure.While this may not seem such a big deal it is akin to having a scale that measures length at one end, weight in the middle, and volume at the end.Second, the EDSS generates ordinal scores rather than interval measures.More about that later.Third, the EDSS has been proven less able than other ''disability'' scales to differentiate between individuals at one point in time and detect change in disability over time.These facts undermine the validity of inferences made on the basis of the analysis of EDSS scores.Consequently, we are at risk of making inaccurate inferences about disability in MS every time we use the EDSS.The use of different statistical methods to analyse results acquired from rating scales cannot overcome flaws within the rating scale itself.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jnnp.74.suppl_4.iv22

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 63

Metadata

Authors
Hobart, J.
Venue
Journal of Neurology, Neurosurgery & Psychiatry
Publisher
BMJ
Published
2003-12-01
Volume
74
Issue
90004
Pages
22iv-26
ISSN
0022-3050 (ISSN-L)
OpenAlex
W2049600735
Cited by
63
References
0
FWCI
2.29
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rating scales for neurologists. https://app.cochat.ai/papers/10.1136/jnnp.74.suppl_4.iv22
The paper
Hobart, J. (2003). Rating scales for neurologists. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.74.suppl_4.iv22

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.